InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Arrow Alexander K., Chief Financial Officer. Insider active across 1 companies, notably Protagenic Therapeutics, Inc.\new. In total, 3 filings have been published. Total volume traded: €19k. The latest transaction was disclosed on 17 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€15,48223,000 shares@ €0.67311.32% mcap80.4% of flow
PTIX Common Stock
SEC:0001493152-22-014338:0·
Ideal exit: 11 Feb 2023 (T+270)
€1,8881,000 shares@ €1.8883100.0% of flow
PTIX Common Stock
SEC:0001493152-21-010335·
Ideal exit: 24 Jan 2022 (T+270)
€1,8881,000 shares@ €1.88830.16% mcap9.8% of flow
PTIX Common Stock
SEC:0001493152-21-010335:0·
Ideal exit: 24 Jan 2022 (T+270)
3 of 3 declarations
About Arrow Alexander K.
Arrow Alexander K. is the Chief Financial Officer at Protagenic Therapeutics, Inc. In this role, he oversees the company's financial operations and is involved in strategic decision-making. His expertise in finance allows him to effectively manage financial resources and optimize the company's performance. He collaborates with other executives to ensure growth and profitability.
